{"id":142987,"date":"2023-02-28T07:12:40","date_gmt":"2023-02-28T12:12:40","guid":{"rendered":"https:\/\/44.250.171.167\/?p=142987"},"modified":"2023-02-28T07:12:41","modified_gmt":"2023-02-28T12:12:41","slug":"earnings-devyani-international-limited-nsedevyani-q3fy23-results-out-total-income-rise-27-yoy","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/earnings-devyani-international-limited-nsedevyani-q3fy23-results-out-total-income-rise-27-yoy\/","title":{"rendered":"Earnings | Devyani International Limited (NSE:DEVYANI): Q3FY23 Results Out; Total Income rise 27% YoY"},"content":{"rendered":"\n<p><a href=\"https:\/\/44.250.171.167\/symbol\/devyani\/\">Devyani International Limited (NSE:DEVYANI)<\/a> is a quick-service restaurant (QSR) company based in India that operates multiple food and beverage brands such as KFC, Pizza Hut, and Costa Coffee.<\/p>\n\n\n\n<p>Devyani International Ltd, reported its Q3FY23 results, revealing a significant YoY growth. The consolidated revenue for the quarter increased by 27% YoY to Rs 7,906 million, and EBITDA increased to Rs 1,739 million. The PAT for the quarter stood at Rs 710 million. The brand contribution for Q3 was reported at Rs 1,450 million with margins at 18.3%. For the 9MFY23, the revenue grew by 50% YoY to Rs 22,427 million, and EBITDA increased to Rs 5,037 million. The PAT came in at Rs 2,026 million, and EPS for 9MFY23 was reported at Rs 1.59. The operating EBITDA (pre-IndAS) also grew to Rs 1,172 million with operating EBITDA margins at 14.8%. The company continued to maintain its momentum in new store additions and opened 81 net new stores in Q3FY23, taking the total count to 1,177 as of December 31, 2022.<\/p>\n\n\n\n<p>Commenting on the performance for Q3 &amp; 9M FY23 Mr. Ravi Jaipuria, Non-Executive Chairman, Devyani International Limited said,\u00a0\u201cConsolidated quarterly revenues stood at Rs 7,906 million \u2013 a growth of nearly 27% over the corresponding period last year. Reported EBITDA, on a Post Ind AS basis, reached Rs\u00a01,739 million, resulting in a reported EBITDA margin of 22%. Innovation remains a strong pillar of our growth strategy across our brand portfolio, and we will continue to delight our customers with many such products in the coming quarters. We remain bullish on our brands and the Indian market. We believe that the current consumer demand slow-down is transient and once inflation stabilizes, we expect consumer spending to improve which will help our businesses. In the meantime we remain focused on refining our processes, maintaining product quality and enhancing our execution capabilities.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Devyani International Limited (NSE:DEVYANI) is a quick-service restaurant (QSR) company based in India that operates multiple food and beverage brands such as KFC, Pizza Hut, and Costa Coffee. Devyani International Ltd, reported its Q3FY23 results, revealing a significant YoY growth. The consolidated revenue for the quarter increased by 27% YoY to Rs 7,906 million, and [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392,85],"tags":[10414],"class_list":["post-142987","post","type-post","status-publish","format-standard","hentry","category-earnings","category-retail-stocks","tag-qsr"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":140922,"url":"https:\/\/alphastreet.com\/india\/alkem-laboratories-ltd-nse-alkem-q3-fy23-results-out-total-income-rises-15-yoy\/","url_meta":{"origin":142987,"position":0},"title":"Alkem Laboratories Ltd. (NSE: ALKEM): Q3 FY23 Results Out; Total Income Rises 15% YoY","author":"Divyansh_Kasana","date":"February 10, 2023","format":false,"excerpt":"Alkem Laboratories Ltd.(NSE:ALKEM) is a pharmaceutical company that specializes in developing, manufacturing, and marketing of pharmaceutical and nutraceutical products. The company operates in both the domestic and international markets. It offers a wide range of products in various therapeutic segments such as cardiology, gastroenterology, neurology, orthopedics, and more. Alkem Laboratories\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/bb3df30c-f366-48d9-a0f1-d7a6be8c4ba8.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/bb3df30c-f366-48d9-a0f1-d7a6be8c4ba8.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/bb3df30c-f366-48d9-a0f1-d7a6be8c4ba8.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/bb3df30c-f366-48d9-a0f1-d7a6be8c4ba8.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/bb3df30c-f366-48d9-a0f1-d7a6be8c4ba8.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/bb3df30c-f366-48d9-a0f1-d7a6be8c4ba8.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":142492,"url":"https:\/\/alphastreet.com\/india\/earnings-alkem-laboratories-ltd-nsealkem-q3fy23-results-out-total-income-rise-15-yoy\/","url_meta":{"origin":142987,"position":1},"title":"Earnings | Alkem Laboratories Ltd.(NSE:ALKEM): Q3FY23 Results Out; Total Income rise 15% YoY","author":"Divyansh_Kasana","date":"February 22, 2023","format":false,"excerpt":"Alkem Laboratories Ltd.(NSE:ALKEM) is a pharmaceutical company based in India that specializes in the manufacturing and marketing of generic and branded drugs, including formulations, active pharmaceutical ingredients (APIs), and nutraceuticals. The company was founded in 1973 and has since grown into one of the top pharmaceutical companies in India, with\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":142715,"url":"https:\/\/alphastreet.com\/india\/earnings-birlasoft-limited-nse-bsoft-q3fy23-results-out-total-income-rise-14-yoy\/","url_meta":{"origin":142987,"position":2},"title":"Earnings | Birlasoft Limited (NSE: BSOFT): Q3FY23 Results Out; Total Income rise 14% YoY","author":"Divyansh_Kasana","date":"February 24, 2023","format":false,"excerpt":"Birlasoft Limited (NSE: BSOFT) is an Indian multinational information technology services company that provides a wide range of IT services, including application development, maintenance, and support, enterprise solutions, digital services, testing, infrastructure management, and consulting services to clients in various industries. Birlasoft was founded in 1995 and is headquartered in\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":142741,"url":"https:\/\/alphastreet.com\/india\/earnings-cholamandalam-financial-holdings-ltd-nse-cholafin-q3fy23-results-out-total-income-rise-33-yoy\/","url_meta":{"origin":142987,"position":3},"title":"Earnings |Cholamandalam Financial Holdings Ltd (NSE: CHOLAFIN): Q3FY23 Results Out; Total Income rise 33% YoY","author":"Divyansh_Kasana","date":"February 24, 2023","format":false,"excerpt":"Cholamandalam Financial Holdings Ltd (NSE: CHOLAFIN) is a financial services company based in India. It is a subsidiary of the Murugappa Group and was established in 1961. CFHL is primarily engaged in providing financial services such as asset management, insurance, and wealth management. It also has a significant presence in\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":142343,"url":"https:\/\/alphastreet.com\/india\/earningsaarti-drugs-ltd-nseaartidrugs-q3fy23-results-out-total-income-rise-4-yoy\/","url_meta":{"origin":142987,"position":4},"title":"Earnings|Aarti Drugs Ltd (NSE:AARTIDRUGS): Q3FY23 Results Out; Total Income rise 4% YoY","author":"Divyansh_Kasana","date":"February 21, 2023","format":false,"excerpt":"Aarti Drugs Ltd (NSE:AARTIDRUGS) is a leading Indian pharmaceutical company that specializes in the manufacture and export of bulk drugs. The company has a diverse product portfolio that includes APIs, intermediates, specialty chemicals, and nutraceuticals. Aarti Drugs is headquartered in Mumbai and has manufacturing facilities located in Tarapur, Vapi, and\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":141220,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-limited-nse-ajantapharma-q3-fy23-results-out-total-income-rises-17-yoy\/","url_meta":{"origin":142987,"position":5},"title":"Ajanta Pharma Limited (NSE: AJANTAPHARMA): Q3 FY23 Results Out; Total Income Rises 17% YoY","author":"Divyansh_Kasana","date":"February 13, 2023","format":false,"excerpt":"Ajanta Pharma Limited (NSE: AJANTAPHARMA) is an Indian pharmaceutical company that specializes in the production and distribution of generic drugs. The company has reported its financial results for the third quarter (Q3) of fiscal year 2023 (FY23) and for the first nine months (9M) of the fiscal year. The revenue\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/142987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=142987"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/142987\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=142987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=142987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=142987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}